Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Contract supported by ONR to discover small molecule defensin-mimetics for military use
Subscribe to our email newsletter
PolyMedix and the University of Massachusetts have bagged a phase I Small Business Technology Transfer (STTR) contract, to support research to identify lead antimicrobial compounds against bacterial pathogens.
The contract is sponsored by the Office of Naval Research (ONR). The primary goal of the work funded by the phase I STTR contract, would be to discover antimicrobial compound(s) based on PolyMedix’s new small molecule defensin-mimetics for activity against bacterial pathogens (most relevant to the military), with a particular focus on acinetobacter.
The contract represents the ninth outside supported funding in the form of a grant or research contract and the third related to biodefense, received by PolyMedix.